Prothena (PRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Biogen, Eli Lilly's, Prothena and AC Immune are included in this Analyst Blog.
Biogen, Eli Lilly's, Prothena and AC Immune are included in this Analyst Blog.